-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Equal-Weight on 10x Genomics, Raises Price Target to $22

Benzinga·05/12/2026 16:16:34
Listen to the news
Morgan Stanley analyst Tejas Savant maintains 10x Genomics (NASDAQ:TXG) with a Equal-Weight and raises the price target from $20 to $22.